Insulet Corporation (PODD) is a publicly traded company on the Nasdaq, and its equity ownership is largely held by institutional investors, which is typical for major medical technology firms. The largest shareholders consist of world-renowned asset management firms, mutual fund providers, and institutional investment giants, including entities such as The Vanguard Group, BlackRock, and State Street Corporation. These large financial institutions manage massive portfolios on behalf of individual and corporate clients, and they maintain substantial positions in PODD as part of their broader healthcare and medical technology market indices. While some original venture capital backers or early institutional partners may have smaller remaining stakes, the majority of the voting power and equity is dispersed among these major global financial houses, which monitor the company’s performance and long-term strategic direction closely to ensure the protection and growth of their massive client investments.